Physician

Ali Khademi, DO

According to 2025 Medicare claims, Ali Khademi, DO (NPI: 1427121037) practices osteopathic manipulative therapy in the Santa Cruz-Watsonville, CA market, with the plurality of this provider's patient population coming from Santa Cruz, CA. This provider's primary affiliated billing organization is BAYVIEW GASTROENTEROLOGY MEDICAL CORPORATION (NPI: 1306006879; TIN: 954866193) and primary practice location at 95076-2468.

Khademi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 199 traditional Medicare patients, billed 526 HCPCS/CPT codes, and received $55,515 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 629 prescription claims across 338 beneficiaries totaling $50,114 in drug costs, led by Mesalamine (Mesalamine). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $196,972 to $55,515. Similarly, Part D prescription costs have declined steadily, from $746,167 to $50,114. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$121K$243K2015 Medicare payment: $196,972 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $242,888 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $228,421 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $212,142 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $208,287 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $148,899 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $156,158 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $92,896 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $91,917 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $55,515 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20155081,503$196,972
20166061,880$242,888
20175851,787$228,421
20185971,694$212,142
20195921,606$208,287
20204601,172$148,899
20214271,107$156,158
2022265701$92,896
2023298714$91,917
2024199526$55,515

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$373K$746K2015 Drug cost: $746,167 (USD; Tot_Drug_Cst)2016 Drug cost: $454,291 (USD; Tot_Drug_Cst)2017 Drug cost: $313,142 (USD; Tot_Drug_Cst)2018 Drug cost: $565,284 (USD; Tot_Drug_Cst)2019 Drug cost: $379,045 (USD; Tot_Drug_Cst)2020 Drug cost: $300,857 (USD; Tot_Drug_Cst)2021 Drug cost: $331,082 (USD; Tot_Drug_Cst)2022 Drug cost: $116,112 (USD; Tot_Drug_Cst)2023 Drug cost: $72,664 (USD; Tot_Drug_Cst)2024 Drug cost: $50,114 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015281595$746,167
2016285721$454,291
2017339832$313,142
2018350937$565,284
2019434973$379,045
2020347810$300,857
2021337782$331,082
2022314637$116,112
2023366656$72,664
2024338629$50,114

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
45385Removal of polyps or growths of large bowel using an endoscope with mechanical snare6363$205
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more3135$131
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more175248$93
45380Biopsy of large bowel using a flexible endoscope108110$86
43239Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope3737$65

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
MesalamineMesalamine482,284$22,759
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates134198$8,385
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl144357$3,216
OmeprazoleOmeprazole1097,043$1,340
SuprepSodium, Potassium,mag Sulfates1424$1,170

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Ali Khademi, DO?

Tedicare shows public-source Medicare data for Ali Khademi, DO (NPI 1427121037), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ali Khademi, DO have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ali Khademi, DO?

Ali Khademi, DO is linked to BAYVIEW GASTROENTEROLOGY MEDICAL CORPORATION (billing NPI 1306006879) in the available physician profile data.

Does Ali Khademi, DO have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.